Supplementary Fig. S2 from Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer
crossref（2023）
摘要
Supplementary Fig. S2. Nuclear and cytoskeletal reorganization by the treatment in metastatic breast cancer cells.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要